Navigation Links
Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product
Date:3/28/2008

SAN DIEGO, March 28 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced the company's licensee, AnGes MG, Inc., reported submission on March 27, 2008, of a New Drug Application (NDA) to the Japanese Ministry of Health, Labor and Welfare for its angiogenesis product candidate, Collategene, for treatment of critical limb ischemia. The treatment uses Vical technology to deliver a gene encoding hepatocyte growth factor (HGF), a human protein that causes growth of blood vessels in areas of restricted blood flow.

"The Japanese NDA filing positions Collategene to be the first product based on our DNA delivery technology with the potential to be approved for human use," said Vijay B. Samant, President and Chief Executive Officer of Vical. "In the United States, where it is estimated that more than 10 million people have peripheral arterial disease (PAD), AnGes already has completed two Phase 2 clinical trials of Collategene in PAD patients. This product candidate offers a novel approach to addressing an important, unserved medical need in the Japanese market, and has the potential to expand into the much larger markets worldwide. This NDA filing by AnGes is an important milestone in advancing nonviral gene therapy toward regulatory and commercial acceptance."

The NDA submission follows positive results announced in June 2007 following interim analysis of data from the first 41 subjects to complete a Phase 3 trial of Collategene. Based on the findings that the primary efficacy endpoint in the trial had been achieved with statistical significance and that there were no major safety concerns related to treatment, an Independent Data Monitoring Committee recommended stopping the trial early to prevent potential e
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vical to Present at Cowen and Company Health Care Conference
2. Vical to Present at BIO and BVGH Global Health Partnering Event
3. Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention
4. Vical to Participate in Pandemic Influenza Panel at JPMorgan Healthcare Conference
5. New Online Learning Tool Fills the Knowledge Gap on Botulinum Toxin Type B for Cervical Dystonia
6. Vical Launches Redesigned Website
7. Vical Presentation at Military Pandemic Influenza Workshop
8. Amedica Receives FDA 510(k) Clearance for Valeo(TM) Cervical Plate
9. Vical to Present at Investor Conferences
10. Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening
11. Vical Announces News Release and Conference Call Schedule for Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Green & Grow Inc. ... B funding and secured Otter Capital as a significant ... accelerate commercialization of GGI’s Agriplier™ technology, building on recent ... , “Since our first meeting, we have been impressed ... product space,” said Alan Sobba, President and CEO of ...
(Date:8/27/2014)... is how plants survive impact by the huge ... while using this energy for photosynthesis. The hypothesis ... blades quickly dissipate the energy throughout the entire ... DTU Physics have now managed to successfully ,film, ... contain light-absorbing proteins which play a role in ...
(Date:8/27/2014)... N.J. , Aug. 27, 2014  A ... potential to help physicians better identify early-stage disease, ... and disability, according to a new study in ... Quest Diagnostics (NYSE: DGX ) and ... the 14-3-3eta protein outperformed conventional antibody-serum testing, including ...
(Date:8/27/2014)... 2014 Research and Markets has ... Pulp & Paper Industry Report 2014" report to ... Pulp & Paper Industry Report 2014 is a professional ... global enzyme for pulp & paper industry. ... including definitions, classifications, applications and industry chain structure. The ...
Breaking Biology Technology:Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3DTU researchers film protein quake for the first time 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Global Enzyme for Pulp & Paper Industry Report 2014 2
... CRY ), a,biomaterials, medical device and tissue processing ... the FBR Capital Markets Annual,Spring Investor Conference, Thursday, May ... City., Steven G. Anderson, president and chief executive ... Time., CryoLife,s live presentation may be accessed through ...
... May 28 /Xinhua-PRNewswire-FirstCall/ -- AMAG,Pharmaceuticals, Inc. (Nasdaq: ... SSRX ), a,leading Chinese biotechnology company, ... commercialization agreement for ferumoxytol, an intravenous,iron replacement ... deficiency,anemia in chronic kidney disease (CKD) patients., ...
... May 27 CellCyte Genetics,Corporation (CellCyte) (OTC ... provide shareholders, potential investors and journalists,with accurate ... Room powered Web site: http://www.cellcyte.com ... or sources for stories from,CellCyte can access ...
Cached Biology Technology:CryoLife to Present at FBR Capital Markets Annual Spring Investor Conference 2AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China 2AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China 3
(Date:8/27/2014)... species frequently found in forests has created a thriving ... toads, a new University of Georgia study has found. ... U.S. in the early 1900s, is one of the ... than a dozen states in the past century, particularly ... forests, it can survive in widely diverse ecosystems and ...
(Date:8/27/2014)... the greatest risk to Europe based upon a proxy ... researchers using a ,big data, approach to scientific research. ... and Global Health ranked the top 100 pathogens affecting ... a system which, they believe, will help governments across ... of infectious diseases, including as a result of climate ...
(Date:8/27/2014)... frightening beasts. But every creature is a baby once. ... fossils of 24 very young dinosaurs and one older ... by a caretaker, according to a new study by ... and Peter Dodson led the work, collaborating with researchers ... specimen is held. Hedrick is a doctoral student in ...
Breaking Biology News(10 mins):More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3Big data approach identifies Europe's most dangerous human and domestic animal pathogens 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 3
... Roughly half the world,s population still lives in areas at ... cases of malaria are reported annually on average. ... mosquito-borne diseases is to decrease the number of mosquitoes. ... California, Riverside from the National Institute of Allergy and ...
... Women,s Hospital and the Harvard School of Public ... pollution and sleep-disordered breathing (SDB), a known cause ... Redline, MD, MPH, Diane Gold, M.D., M.P.H. and ... temperature increases and sleep-disordered breathing using data from ...
... many carnivores eat fruit, but had thought this was ... Santiago de Compostela (USC) have shown that carnivorous animals ... in helping fruiting plants to reproduce and disperse their ... mammals and plants as irrelevant, a team of researchers ...
Cached Biology News:UCR entomologists to develop special bacteria to combat spread of mosquito-borne diseases 2UCR entomologists to develop special bacteria to combat spread of mosquito-borne diseases 3UCR entomologists to develop special bacteria to combat spread of mosquito-borne diseases 4New link between pollution, temperature and sleep-disordered breathing 2New link between pollution, temperature and sleep-disordered breathing 3Carnivorous mammals track fruit abundance 2
... Antibody Capture Kit eliminates ... optimization steps typically required ... This kit enables the ... multiple antigens based on ...
...
... CLS number is a new product ... product number. If showing no availability ... Sigma-Aldrich number (R4276) or contact customer ... polystyrene (expanded surface, easy grip) ...
... Services offer a full range of peptide ... Services include: Peptide synthesis, crude product ... synthesis, purified product (70-95% pure) ... fluorescein, myristylation, phosphorylation, and rhodamine) ...
Biology Products: